Raquel Martínez

发表

AICAR Stimulates the Pluripotency Transcriptional Complex in Embryonic Stem Cells Mediated by PI3K, GSK3β, and β-Catenin

S. López, B. Soria, F. Bedoya, 2020, ACS omega.

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.

Jacques Fellay, Amalio Telenti, Huldrych F Günthard, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Counteraction of HLA-C-Mediated Immune Control of HIV-1 by Nef

D. Goldstein, M. Carrington, J. Fellay, 2010, Journal of Virology.

Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals.

Matthias Cavassini, Patrick Taffé, Amalio Telenti, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Role of common human TRIM5α variants in HIV-1 disease progression

Amalio Telenti, A. Telenti, M. May, 2006, Retrovirology.

Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.

A. Telenti, R. Weber, M. Battegay, 2005, The Journal of infectious diseases.

ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir

Matthias Cavassini, Amalio Telenti, Hansjakob Furrer, 2010, Pharmacogenetics and genomics.

Use of a Combined Ex Vivo/In Vivo Population Approach for Screening of Human Genes Involved in the Human Immunodeficiency Virus Type 1 Life Cycle for Variants Influencing Disease Progression

J. Beckmann, J. Ott, A. Telenti, 2005, Journal of Virology.

Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors.

A. Telenti, P. Sudre, P Sudre, 2000, AIDS research and human retroviruses.

Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals

A. Telenti, H. Günthard, T. Buclin, 2013, Pharmacogenetics and genomics.

Patterns of evolution of host proteins involved in retroviral pathogenesis

A. Telenti, H. Kaessmann, G. Bleiber, 2006, Retrovirology.

Contribution of Genome-Wide Significant Single-Nucleotide Polymorphisms and Antiretroviral Therapy to Dyslipidemia in HIV-Infected Individuals: A Longitudinal Study

Matthias Cavassini, Patrick Taffé, Amalio Telenti, 2009, Circulation. Cardiovascular genetics.

Susceptibility and adaptation to human TRIM5α alleles at positive selected sites in HIV-1 capsid.

A. Telenti, P. McLaren, J. Snoeck, 2013, Virology.

Entry and Transcription as Key Determinants of Differences in CD4 T-Cell Permissiveness to Human Immunodeficiency Virus Type 1 Infection

A. Telenti, H. Günthard, A. Oxenius, 2004, Journal of Virology.

Genetic Diversity of EBV-Encoded LMP1 in the Swiss HIV Cohort Study and Implication for NF-Κb Activation

A. Telenti, M. Battegay, M. Tinguely, 2012, PloS one.

Innate immune defects in HIV permissive cell lines

A. Telenti, A. Ciuffi, T. Roger, 2016, Retrovirology.

Host and Viral Genetic Correlates of Clinical Definitions of HIV-1 Disease Progression

A. Telenti, H. Günthard, A. Rauch, 2010, PloS one.

Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque.

P. D. de Bakker, J. Fellay, A. Telenti, 2011, The Journal of clinical investigation.

Dynamics of HIV Latency and Reactivation in a Primary CD4+ T Cell Model

J. Fellay, A. Telenti, N. Beerenwinkel, 2014, PLoS pathogens.

Estimating the Net Contribution of Interleukin-28B Variation to Spontaneous Hepatitis C Virus Clearance

Jacques Fellay, Dermot Kelleher, Amalio Telenti, 2011, Hepatology.

The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir.

Jacques Fellay, Amalio Telenti, Hansjakob Furrer, 2008, The Journal of infectious diseases.

Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study.

Matthias Cavassini, Amalio Telenti, Hansjakob Furrer, 2011, The Journal of infectious diseases.

No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy.

A. Telenti, H. Günthard, H. Furrer, 2011, The Journal of infectious diseases.

MDR1 genetic polymorphism does not modify either cell permissiveness to HIV-1 or disease progression before treatment.

A. Telenti, M. Egger, C. Marzolini, 2004, The Journal of infectious diseases.

Analysis of Natural Variants of the Human Immunodeficiency Virus Type 1 gag-pol Frameshift Stem-Loop Structure

A. Telenti, M. Muñoz, Gilbert GREUB, 2002, Journal of Virology.

Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals.

A. Telenti, M. Egger, R. Weber, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Role of common human TRIM5α variants in HIV-1 disease progression

Gabriela Bleiber, Raquel Martínez, Amalio Telenti, 2006, Retrovirology.